$Gilead Sciences(GILD)$
$Gilead Sciences (GILD) Scores +2.45%: Gilead Sciences Defends $150 Breakout Zone, Arcellx M&A Keeps Bulls Charging
Latest Close Data 📊 GILD closed at $149.92 on Sep 2, 2026, gaining +2.45% (+$3.58). Price is just -4.7% below its 52-week high of $157.29. Pre/after-hours quotes held near $150, signaling persistent bid.
Core Market Drivers 📰 Gilead’s $7.8B Arcellx acquisition continues fueling oncology pipeline enthusiasm. Q2 revenue of $7.8B beat estimates while full-year loss guidance tightened, reinforcing the fundamental turnaround narrative. Broad healthcare rotation adds tailwind.
Technical Analysis 🧭 Volume hit 4.87M shares (Volume Ratio 0.96). MACD remains bullish at +2.18 with DIF (4.30) well above DEA (3.22). RSI6 rebounded to 69.8 after cooling from overbought — a healthy reset. KDJ shows K (79.9) crossing above D (80.3), confirming renewed momentum.
Key Price Levels 🎯
-
Immediate Pivot: $149.55 — yesterday’s resistance, now reclaimed
-
Primary Support: $131.66 — Aug 31 swing low; major floor
-
Strong Resistance: $157.29 — 52-week high; breakout targets $165+
Valuation Perspective 💎 P/E TTM is -57.3x (GAAP negative due to impairment), but Forward P/E sits at -336x — distorted by near-term acquisition costs. P/S TTM of 6.11x remains elevated vs. pharma peers; P/B of 15.72x reflects heavy intangibles. Dividend yield of 2.15% offers income cushion.
Analyst Targets 🏦 27 institutions cover GILD with 7 Strong Buy, 18 Buy, 6 Hold. Average target: $157.79 (median ~$158), range $123–$180. Consensus implies +5.3% upside from current price.
Weekly Outlook 🔮 Expect consolidation between $146.91–$152 as price digests the $150 breakout. A weekly close above $150.50 opens path to retest $157.29. Failure to hold $146.91 risks slide toward $131.66 support. RSI6 staying above 60 keeps dip-buying bias intact.
⚠️ Risk Disclaimer: Technical analysis is probabilistic, not predictive. Past performance does not guarantee future results. This is not investment advice.
🎯$Gilead Sciences (GILD) Options Strategy: Bull Call Spread (Debit Spread)
-
Underlying: GILD (Gilead Sciences)
-
Market View: Cautiously bullish / breakout continuation above $150
-
Strategy Type: Debit spread / directional long
-
Option Contract Portfolio:
-
Buy 1x $150 Call expiring 2026-09-11 @ $2.51 (mid)
-
Sell 1x $155 Call expiring 2026-09-11 @ $0.88 (mid)
-
-
Max Gain & Loss:
-
Max Gain: ($155 - $150 - $1.63) x 100 = $337 per spread
-
Max Loss: $163 per spread (net debit paid)
-
-
Initial Cost/Credit: Net Debit = $2.51 - $0.88 = $1.63 (or $163 per spread)
Investing is a long journey. Knowing when to move matters — and so does knowing when to recharge.
Markets may not slow down, but you can. Whether it’s a quick break between trading sessions or a long journey, staying comfortable helps you reset for what comes next. The new Night Trading Memory Foam Pillow features 360° ergonomic support and slow-rebound memory foam that gently conforms to your neck, plus a roll-up design that makes it easy to bring wherever you go.
https://laohu8.com/J/redeemGift?goodID=100540&type=delivery
Redeem the new Night Trading Memory Foam Pillow in Tiger Coins Mall, and stay supported for the journey ahead.
Comments